Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance

Pankaj Taneja, Dejan Maglic, Fumitake Kai, Sinan Zhu, Robert D. Kendig, A. Elizabeth, Kazushi Inoue
ISSN / E-ISSN
— / —
DOI
10.4137/cmo.s4773 ↗
Volume · Issue · Pages
4 · — · 15-34
Publisher
Libertas Academica Ltd.
Article URL
https://doi.org/10.4137/cmo.s4773 ↗
Article details
Unverified
Publication date (each date has its type and source)
01 Jan 2010
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date01 Jan 2010 OpenAlex

Keywords (as given): breast cancer; prognostic factors; estrogen receptor; progesterone receptor; HER2; trastuzumab; Ki-67; TP53 mutation; cyclin D1; cyclin E1; BRCA1/2; p14ARF; vascular endothelial growth factor; endocrine therapy; chemotherapy response

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
Clinical Medicine Insights: Oncology
Publication date used
01 Jan 2010 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.